Curriculum Vitae, Jerker Westin
09 January 2016 . Photo: Dalarna University)
Born 1971, married, having three sons born 1997, 1999 and 2011, living in Orsa, Sweden.
, Skype: jewestin
Tel: +46 250 48 048, +46 70 289 12 18
Senior Lecturer, Computer Engineering, Dalarna University (2011 – present).
Lecturer, Computer Engineering, Dalarna University (2001 – 2010).
Development Engineer, Customer Operations, Clinitrac AB (Electronic patient diaries for clinical studies) (1999 – 2001).
Development Engineer, Consultant, Styrex AB (IT systems) (1998 – 1999).
Development Engineer, Biochemistry, Biacore AB (Biosensors) (1996 – 1997).
Summer jobs at laboratories, Karolinska University Hospital, Uppsala University Hospital, Pharmacia Ophthalmics and Pharmacia Biosensor (1991 – 1996).
Doctor of Philosophy in Medical Informatics, Uppsala University. Decision support for treatment of patients with advanced Parkinson’s disease.
Acta Universitatis Upsaliensis. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 621. 2010.
One year's courses in Computer Science, Pharmacology and Economics (1996 – 2010).
Master of Science in Engineering (civilingenjör) Molecular Biotechnology, Uppsala University (1996). Thesis on biomaterial surfaces/immunology.
High School Diplomas, S:t Mikaelsskolan, Mora, Sweden (1991) and Winona Senior High School, Minnesota, USA (1990).
Lecturing experience in Swedish and English languages:
Courses in data mining, fuzzy logic, neural networks, artificial intelligence, software engineering, databases and internet applications (2001 – 2012).
Completed qualifying education – Scholarship of teaching in higher education (2011).
Completed qualifying course for supervisors in research education (2011).
Assistant supervisor of two currently active PhD students.
Supervision of approximately 30 completed Master theses (2005 – 2012).
Owner and board member of Jemardator AB, holder of patent application
Movement Disorder Monitoring (2006). Sealed patent in Australia 2011.
Occasional consultancy work in own enterprise.
Deputy board member of my father's company Hjärnbirger Orsa AB.
Selected articles in peer-reviewed journals:
Validation of a home environment test battery for supporting assessments in advanced Parkinson's disease.
Deputy manager of the research project E-MOTIONS (2010 – 2012).
Participant in previous research projects IDOL and MOVISTAR (2003 – 2009).
J Westin, M Schiavella, M Memedi, D Nyholm, M Dougherty, A Antonini.Neurol Sci. 2011; in pressMethods for detection of speech impairment using mobile devices.
T Khan, J Westin.
Recent Patents on Signal Processing. 2011; 1(2)163-171Methods for detection of handwriting/drawing impairment using inputs from touch screens.
M Memedi, J Westin.
Recent Patents on Signal Processing 2011; 1(2)156-162A web application for follow-up of results from a mobile device test battery for Parkinson's disease patients.
M Memedi, J Westin, D Nyholm, M Dougherty, T Groth.Comput Meth Prog Biomed. 2011; 104(2):219-226.A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.
J Westin, D Nyholm, S Pålhagen, T Willows, T Groth, M Dougherty, M Karlsson.Clin Neuropharmacol. 2011; 34(2):61-65.A home environment test battery for status assessment in patients with motor fluctuations.
J Westin, M Dougherty, D Nyholm, T Groth.Comput Meth Prog Biomed. 2010; 98 (1): 27-35.A new computer method for assessing drawing impairment in Parkinson's disease.
J Westin, S Ghiamati, M Memedi, D Nyholm, A Johansson, M Dougherty, T Groth.J Neurosci Meth. 2010; 190(1):143-148.Classification of structural timber by decision trees: a comparison to the certified method.
M Brännström, J Westin.
Forest Products Journal. 2009; 59(3):53-61.Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease.
J Westin, D Nyholm, T Groth, M Dougherty, P Yerramsetty, S Pålhagen.Parkinsonism Relat Disord. 2006; 12(8):509-513.Complement C3b interactions studied with surface plasmon resonance technique.
S Jokiranta, J Westin, U Nilsson, B Nilsson, J Hellwage, S Löfås, DL Gordon, KN Ekdahl, S Meri.Int Immunopharmacol. 2001; 1(3):495-506.